Preventing genetic damage with BIX - a novel player in the DNA damage response pathway

利用 BIX 预防基因损伤——DNA 损伤反应途径中的新参与者

• 批准号: DP0666861
• 负责人: A/Prof Megan Chircop
• 金额: $ 18.36万
• 依托单位: Griffith University
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2006
• 资助国家: 澳大利亚
• 起止时间: 2006-01-01 至 2009-01-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP0666861
• 关键词: Preventing; genetic; damage; BIX; novel

Defects in the DNA damage-response pathway underpin many human genetic disorders and diseases, including cancer. A detailed understanding of this process has enormous implications for future medicine. Our characterization of a novel protein involved in DNA damage signalling will help in screening inhibitors of this pathway that could be applied in chemo-and/or radiotherapy. This proposal will place Australia among the leaders in this internationally significant and highly competitive area of research leading to the creation of new compounds. Capture of this technology will create the opportunity for IP income, novel exports and new enterprises for Australia.

DNA损伤反应途径的缺陷是许多人类遗传疾病和疾病的基础，包括癌症。对这一过程的详细了解对未来的医学有着巨大的意义。我们对一种参与DNA损伤信号传导的新型蛋白质的表征将有助于筛选可应用于化疗和/或放疗的该途径的抑制剂。该提案将使澳大利亚成为这一具有国际意义和高度竞争力的研究领域的领导者，从而创造新的化合物。掌握这一技术将为澳大利亚创造知识产权收入、新型出口和新企业的机会。